Corpus ID: 8987246

[Prolonged neuromuscular blockade with vecuronium in patient with triple pregnancy treated with magnesium sulfate].

@article{Hino1997ProlongedNB,
  title={[Prolonged neuromuscular blockade with vecuronium in patient with triple pregnancy treated with magnesium sulfate].},
  author={Hirofumi Hino and I. Kaneko and Akiko Miyazawa and Tadashi Aoki and Bunpei Ishizuka and K Kosugi and Akira Amemiya},
  journal={Masui. The Japanese journal of anesthesiology},
  year={1997},
  volume={46 2},
  pages={
          266-70
        }
}
A 33 year-old parturient with triplet pregnancy underwent emergency cesarean section at 35 week of gestation under general anesthesia. The patient had received magnesium sulfate to prevent uterine contraction immediately before the cesarean section. Although serum magnesium value was not beyond therapeutic levels (3.3 mEq.l-1), the neuromuscular blocking effects with vecronium were strengthened. It was not likely that volatile anesthetic enhanced neuromuscular blockade produced by vecuronium… Expand
[Use of magnesium sulfate in anesthesiology].
TLDR
It was determined that when magnesium sulfate is used for anesthesia, the smaller doses of fentanyl and myorelaxants are needed and their action is strengthened, and magnesium does not prolong the activity of painkiller substances. Expand
Maternal adverse effects of different antenatal magnesium sulphate regimens for improving maternal and infant outcomes: a systematic review
TLDR
Appropriate administration of antenatal magnesium sulphate was not shown to be associated with serious maternal adverse effects, Though an increase in 'minor’ adverse effects and treatment cessation was shown, and adverse effect estimates from studies of other designs largely supported data from randomised trials. Expand